Abstract: Self-renewal is an indispensable property that allows stem cells to regenerate and maintain the homeostasis of functionally diverse cell populations. Deregulation of self-renewal in hematopoietic stem cell (HSC) directly linksto a number of hematopoietic degenerative disorders including bone marrow failure and various blood diseases, whereas its aberrant activation is a defining and indispensable feature of leukemia stem cells (LSCs) that sustain the malignant phenotypes. We and others have shown that self-renewal of acute myeloid leukemia (AML) stemcells heavily rely on the key component of canonical Wnt signaling pathway, β-catenin and the homeobox protein,HOXA9 that are largely dispensable for adult HSCs. Although these findings reveal a contrasting functional requirement and a potential therapeutic opportunity for AML, development of small molecule inhibitors against oncogenic transcription factors has so far met with very little success largely due to our lack of understanding about the molecular regulations of these proteins in mediating hematopoietic self-renewal, which has significantlyhindered progress in developing effective therapeutic strategies to treat the resultant diseases. Intriguingly, wehave recently revealed coregulation of both canonical Wnt pathway and posterior HOXA loci including HOXA9by the long non-coding RNA (lncRNA), HOTTIP. Strikingly, we also report a novel crosstalk between β-cateninand HOXA9 that can override their individual requirement in both mouse and human AML of HSC origins. In search for crucial mediators for β-catenin and Hoxa9 functions, we further identified that protein argininemethyltransferase 1 (PRMT1), which also implicates in DNA damage and repair (DDR), can functionally replaceHOXA9 or β-caten in in AML stem cell originated from HSCs. PRMT1 together with DDR complex are unbiased lyisolated along with CTCF/cohesin complex, hematopoietic transcription factors (TFs) and nucleosome remodeling factors as HOTTIP interacting partners by ChIRP-MS in AML cells. These findings not only discover a novel HOTTIP/β-catenin-HOXA9/PRMT1 axis critical for mediating hematopoietic self-renewal, but also lead to central hypothesis that HOTTIP/β-catenin-HOXA9/PRMT1 axis coordinates hematopoietic self-renewal and characterization of the functions of individual components and their crosstalk along the axis regulates hematopoietic specific transcription networks and DDR pathways to modulate hematopoietic self-renewal in the disease setting. In this proposal, we will 1 decipher cooperative action of HOTTIP and hematopoietic TFs in regulating HOXA9 and β-catenin axis; 2) dissect the molecular functions and regulation of β-catenin-HOXA9/Prmt1 axis during normal and malignant hematopoiesis. Success completion of proposed studies not only will establish the molecular principles, but also facilitate the design of specific therapeutics in modulating self-renewal activities in normal and malignant stem cells, which can be potentially translated into patient benefits.
|Effective start/end date
|7/1/22 → 6/30/23
- National Cancer Institute: $520,285.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.